Feature Reviews in Tumor Immunology
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 552
Special Issue Editor
2. School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK
Interests: tumor immunology; autoimmunity; RNA sequencing; immunotranscriptomics; translational oncology; immunoregulatory cytokines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is now more than five decades since the fields of immunology and oncology were proven to be inextricably linked, overlapping and interacting with each other. From the next generation of hallmarks outlined by Hanahan and Weinberg in Cell in 2011 to the successful routine use of immunotherapies and novel immune strategies in clinical trials, advances in the management of human tumors and improvements in the quality of life of patients have been impressive.
Unravelling the cellular and molecular pathogenetic mechanisms involved in the tumor microenvironment and the activities of immune cell compartments have paved the way for the development of interventions with monoclonal antibodies, immune checkpoint inhibitors, vaccines, cytokines, immunomodulators and CAR-T cells to prevent or inhibit immune escape and enhance anti-tumor immunity.
However, while the data gathered so far form a solid basis for future advances in the field, many questions regarding the optimal management of human malignancies remain. This Special Issue welcomes the submission of recent review articles that address immune-related pathogenetic mechanisms, the cellular and molecular networks underlying human tumors, current, novel and future approaches to their exploration, current and future immunotherapeutics, and ongoing pre-clinical and clinical studies on immunotherapies.
Dr. Maria-Ioanna Christodoulou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor immunity
- immunotherapy
- engineered immune cells
- antibodies
- immunomodulators
- cytokines
- survival
- immune-checkpoint inhibitors
- tumor immune microenvironment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
